Menu

GRenSSAP
GRenSSAP

Group leader
avatar_investigadors.jpg
Anna Berenguera Ossó
aberenguera@idiapjgol.org
avatar_grups_recerca.png

Publications

Corrigendum to “A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases” [Vaccine 42 (12) (2024) 3039-3048].

Schultze A, Martin I, Messina D, Bots S, Belitser S, Carreras-Martínez JJ, Correcher-Martinez E, Urchueguía-Fornes A, Martín-Pérez M, García-Poza P, Villalobos F, Pallejà-Millán M, Bissacco CA, Segundo E, Souverein P, Riefolo F, Durán CE, Gini R, Sturkenboom M, Klungel O and Douglas I
Vaccine. 2025 Jan 12; . doi:10.1016/j.vaccine.2024.126438; PMID:39396886

See more:
Incidence of severe and non-severe SARS-CoV-2 infections in children and adolescents: a population-based cohort study using six healthcare databases from Italy, Spain, and Norway.

Durán CE, Riefolo F, Gini R, Barbieri E, Messina D, Garcia P, Martin M, Villalobos F, Stona L, Carreras JJ, Urchueguía A, Correcher-Martínez E, Zhao J, Lupattelli A, Nordeng H and Sturkenboom M
EUROPEAN JOURNAL OF PEDIATRICS. 2024 Nov 13; . doi:10.1007/s00431-024-05864-1; PMID:39535547

See more:
Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example.

Bots SH, Belitser S, Groenwold RHH, Durán CE, Riera-Arnau J, Schultze A, Messina D, Segundo E, Douglas I, Carreras JJ, Garcia-Poza P, Gini R, Huerta C, Martín-Pérez M, Martin I, Paoletti O, Bissacco CA, Correcher-Martínez E, Souverein P, Urchuequía A, Villalobos F, Sturkenboom MCJM and Klungel OH
AMERICAN JOURNAL OF EPIDEMIOLOGY. 2024 Nov 4; . doi:10.1093/aje/kwae172; PMID:38960670

See more:
Delivering an innovative multi-infection and female genital mutilation screening to high-risk migrant populations (ISMiHealth): study protocol of a cluster randomised controlled trial with embedded process evaluation

A. CRUZ, A. CUXART-GRAELL, A. GONCALVES, J. VAZQUEZ-VILLEGAS, S. VALLEJO-GODOY, J. SALAS-CORONAS, N. PIQUERAS, S. MARTINEZ-TORRES, E. ARTIGUES-BARBERA, Y. RANDO-MATOS, A. MARGALEJO, J. VIZCAINO, P. REQUENA, A. MARTINEZ-PEREZ, E. FERRER, L. MENDEZ-BOO, E. COMA, M. LUZON-GARCIA, E. SEQUEIRA-AYMAR, A. CASELLAS, M. VAZQUEZ, C. JACQUES-AVINO, L. MEDINA-PERUCHA, E. SICURI, S. EVANGELIDOU, C. AGUILAR MARTIN and A. REQUENA-MENDEZ
BMJ Open. 2024 Nov 4; . doi:10.1136/bmjopen-2023-078337; PMID:39496367

See more:
Safety of the Janssen COVID-19 vaccine (JCOVDEN) using VAC4EU European Healthcare Data Sources: Methods and Results of the Second Study Feasibility Assessment

F. AHMADIZAR, J. FORTUNY, A. ROYO, E. PLANA, R. WEINRIB, R. ESTEBAN, K. BORIC, N. YEFIMENKO, M. HAUGH, J. CARRERAS, A. URCHUEGUÍA-FORNES, E. CORRECHER, J. VAN DEN BERG, T. LYSEN, F. VILLALOBOS, C. BISSACCO, E. NEWBERN, C. WILLAME, N. PRAET and M. STURKENBOOM
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

See more:

Board of Trustees

Collaborators

Accreditations